Particle | Study | Model | Endpoint | COV in controls (%) | BMR (%) | BMDL (cm2/cm2) | BMDU (cm2/cm2) | Magnitude change [log10(BMDU) – log10(BMDL)] |
---|---|---|---|---|---|---|---|---|
Nano-CeO2 | in vivo IVIVE | Rat inhalation | PMN | n.d.—99.08 | 100 | 0.117 | 0.287 | 0.390 |
Nano-CeO2 | Cappellini et al. [57] | A549 + dTHP-1 (sub.) | IL-1β | 42.23 | 20 | 0.593 | 7.4 | 1.096 |
Nano-CeO2 | Cappellini et al. [57] | A549 + dTHP-1 (sub.) | IL-6 | 12.23 | 20 | 2.44 | 7.92 | 0.511 |
Nano-CeO2 (23) | Kim et al. [58] | MH-S | IL-6 | 43.30 | 20 | 0.00651 | 0.0833 | 1.107 |
Nano-CeO2 (88) | Kim et al. [58] | MH-S | IL-6 | 43.30 | 20 | 0.00335 | 0.0322 | 0.983 |